Search Results - "Indihar, V."

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study by Rowe, S.M., Zuckerman, J.B., Dorgan, D., Lascano, J., McCoy, K., Jain, M., Schechter, M.S., Lommatzsch, S., Indihar, V., Lechtzin, N., McBennett, K., Callison, C., Brown, C., Liou, T.G., MacDonald, K.D., Nasr, S.Z., Bodie, S., Vaughn, M., Meltzer, E.B., Barbier, A.J.

“…•CFTR mRNA was delivered by aerosol in lipid nanoparticles to cystic fibrosis adults.•In this small first-in-human study treatment was generally safe and well…”
Get full text

537 Increasing annual oral glucose tolerance test adherence by routine screening and on-site testing by Riddle, J., Indihar, V., Oder, A., Kopras, E.

Get full text

340 Nurses’ knowledge of palliative care by Oder, A., Mullins, K., Indihar, V., Duncan, K.

Get full text

522: Impact of elexacaftor/tezacaftor/ivacaftor on respiratory bacterial cultures in adult patients with cystic fibrosis by Finke, J., Kaitlyn, B., Indihar, V., Oder, A.

Get full text

308: Depression and anxiety score changes after elexacaftor/tezacaftor/ivacaftor: University of Cincinnati adult CF center experience by Blackwelder, J., Oder, A., Finke, J., Indihar, V., Vonbokern, L., Meyers, M., Meyer, B., Riddle, J.

Get full text

316 Depression and anxiety scores after highly effective cmodulator therapy in pandemic times in an adult cystic fibrosis clinic by Blackwelder, J., Indihar, V., Finke, J., Oder, A., Riddle, J., Meyers, M., Kopras, E., Khawar, M., Meyer, B., Vonbokern, L.

Get full text

27 Effect of SARS-CoV-2 on long-term physical and mental health symptoms in people with cystic fibrosis and their caregivers by Hudock, K., Cheng, P., Chmiel, J., Brown, C., Kramer, E., Indihar, V., Kopras, E., Aliaj, E., Hudson, J., Filigno, S.

Get full text

130: Feedback from patients regarding their use of home spirometers by Oder, A., Indihar, V., Meyers, M., Vonbokern, L., Meyer, B., Riddle, J., Finke, J., Shively, L., Hostetter, A.

Get full text

544: Safety and tolerability of single and repeat doses of MRT5005, an inhaled CFTR mRNA replacement therapy, in adult CF patients by Rowe, S., Dorgan, D., Lascano, J., Zuckerman, J., McCoy, K., Jain, M., Schechter, M., Lommatzsch, S., Indihar, V., Lechtzin, N., McBennett, K., Callison, J., Brown, C., Liou, T., MacDonald, K., Nasr, S., Bodie, S., Meltzer, E., Barbier, A.

Get full text